{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae Single/Multi-Panel Drug Screen Dip Card Tests",
        "Chemtrue\u00ae Single/Multi-Panel Drug Screen Cassette Tests"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "k123080",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXM",
        "DIS",
        "DJC",
        "DJR",
        "DNK",
        "DJG"
    ],
    "Summary Letter Date": "November 29, 2012",
    "Summary Letter Received Date": "October 25, 2012",
    "Submission Date": "September 28, 2012",
    "Regulation Number(s)": [
        "21CFR862.3170"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzodiazepines",
        "Barbiturates",
        "Ecstasy (MDMA/XTC)",
        "Methadone",
        "Opiates (Morphine)",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Colloidal gold-based competitive immunoassay",
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative screening",
        "Lateral flow",
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Dip Card",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue\u00ae Single/Multi-Panel Drug Screen Dip Card and Cassette Tests, rapid qualitative immunoassays for drugs of abuse in urine",
    "Indications for Use Summary": "Qualitative detection of up to six drugs of abuse (benzodiazepines, barbiturates, ecstasy, methadone, opiates, oxycodone) in human urine, for healthcare professional, in vitro diagnostic, and over-the-counter use",
    "fda_folder": "Toxicology"
}